Current Position & Awards

Dr. Jane Pei-Chen Chang is a consultant psychiatrist at the Department of Psychiatry at China Medical University Hospital in Taichung, Taiwan. She is also a PhD candidate at the Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Dr. Chang received her MD and MSc from China Medical University and her training in General Psychiatry and Child and Adolescent Psychiatry in Taiwan. Her research interests include in search for novel treatments and biomarkers for depression and attention deficit hyperactivity disorder, with a special focus on omega-3 polyunsaturated fatty acids. Dr. Chang has received several recognitions for her research and academic work, including the World Psychiatric Association (WPA) Young Psychiatrists Award (2012 & 2014, International Association of Child and Adolescent Psychiatry (IACAPAP) Donald J Cohen Fellowship (2014) & Helmut Remschmidt Research Seminar Fellowship Award (2015), World Congress of Asian Psychiatry (WCAP) Sartorius Award (2015), Dr. Paul Janssen Research Award (2015), Junior Clinical British Association for Psychopharmacology (BAP) Psychopharmacology Award (2016), International Society for the Study of Fatty Acids and Lipids (ISSFAL) New Investigator Award (2014 & 2018), Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN)/College of International Psychopharmacology (CINP) Travel Award (2018)

Selected Publications

• Chang JP, Su KP, Mondelli V, Pariante CM. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-Analysis of Clinical Trial and Biological Studies. Neuropsychopharmacology. 2018; 46(3):534-545.
• Chang JP, Chang SS, Yang HT, Palani M, Chen CP, Su KP. Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular (CVDs) with and without depression. Brain Behav Immun. 2015; 44: 28031.
• Su KP, Lai HC, Yang HT, Su WP, Peng CY, Chang JP, Chang HC, Pariante CM. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized controlled trial. Biol Psychiatry. 2014; 76(7): 559-66.
• Chang JP, Lin CY, Lin PY, Shih YH, Chiu TH, Ho M, Yang HT, Huang SY, Galecki P, Su KP. Polyunsaturated fatty acids and inflammatory markers in major depressive episodes during pregnancy. Prog Neuropsychopharmacol Biol Psychiatry 2018; 80: 273-278.
• Chang JP, Lai HC, Yang HT, Su WP, Peng Cy, Galecki P, Walczewska A, Pariante CM, Su KP. Polyunsaturated fatty acids levels and initial presentation of somatic symptoms induced by interferon-alpha and initial presentation of somatic symptoms induced by interferon-alpha therapy in patients with chronic hepatitis C viral infection. Nutritional Neuroscience 2017; 10: 291-296.
• Chang JP, Jingling L, Huang YT, Lu YJ, Su, KP. Delay Aversion, Temporal Processing, and N-3 Fatty Acids, Intake in Children with Attention-Deficit/Hyperactivity Disorder (ADHD). Clinical Psychological Science 2016: 4:1094-1103.
• Nishi D, Su KP, Usuda K, Chang JP, Chiang YJ, Guu TW, Hamazaki K, Nakaya N, Sone T, Hashimoto K, Hamazaki T, Matsuoka YJ. Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: An open-label pilot study. Nutr Neurosci. 2017 (Epub Ahead of Print).
• Su KP, Yang HT, Chang JP, Shih YH, Guu TW, Kumaran SS, Gałecki P, Walczewska A, Pariante CM. Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2017 (Epub ahead of Print).
• Chang JP, Gau SS. Mother-Child Relationship in Youths with Attention-Deficit Hyperactivity Disorder and Their Siblings. J Abnorm Child Psychol. 2017: 45:871-882.
• Gau SS, Chang JP. Maternal parenting styles and mother-child relationships among adolescents with and without persistent attention-deficit/hyperactivity disorder. Research in Developmental Disabilities 2013, 34(5): 1581-94. (shared first author)